| Adverse Event | Global Count of AE reports post Vaccine | Global Rate of reported AE<br/>(count/Month) | Global Rate of reported AE<br/>(count/billion doses) | Global Rate of reported AE<br/>(count/billion people vaccinated) |
| --- | --: | --: | --: | --: |
| Menstrual abnormality | 12843<br/>65 | 714<br/>0.221 | 1060<br/>0.985 | 2460<br/>8.43 |
| Miscarriage | 3338<br/>325 | 185<br/>1.11 | 277<br/>4.92 | 638<br/>42.2 |
| Fetal chromosomal abnormalities | 10<br/>0 | 0.556<br/>0.00 | 0.829<br/>0.00 | 1.91<br/>0.00 |
| Fetal malformation | 22<br/>2 | 1.22<br/>0.00680 | 1.82<br/>0.0303 | 4.21<br/>0.259 |
| Fetal cystic hygroma | 8<br/>0 | 0.444<br/>0.00 | 0.663<br/>0.00 | 1.53<br/>0.00 |
| Fetal cardiac disorders | 18<br/>2 | 1.00<br/>0.00680 | 1.49<br/>0.0303 | 3.44<br/>0.259 |
| Fetal arrhythmia | 5<br/>0 | 0.278<br/>0.00 | 0.414<br/>0.00 | 0.956<br/>0.00 |
| Fetal cardiac arrest | 20<br/>0 | 1.11<br/>0.00 | 1.66<br/>0.00 | 3.82<br/>0.00 |
| Fetal vascular mal-perfusion | 12<br/>0 | 0.667<br/>0.00 | 0.994<br/>0.00 | 2.29<br/>0.00 |
| Fetal growth abnormalities | 188<br/>24 | 10.4<br/>0.0816 | 15.6<br/>0.364 | 35.9<br/>3.11 |
| Fetal abnormal surveillance | 178<br/>45 | 9.89<br/>0.153 | 14.7<br/>0.682 | 34.0<br/>5.84 |
| Fetal placental thrombosis | 6<br/>0 | 0.333<br/>0.00 | 0.497<br/>0.00 | 1.15<br/>0.00 |
| Fetal stillbirth | 402<br/>64 | 22.3<br/>0.218 | 33.3<br/>0.970 | 76.9<br/>8.30 |
| Low amniotic fluid | 17<br/>1 | 0.944<br/>0.00340 | 1.41<br/>0.0152 | 3.25<br/>0.130 |
| Preeclampsia | 133<br/>28 | 7.39<br/>0.0952 | 11.0<br/>0.424 | 25.4<br/>3.63 |
| Premature Delivery | 384<br/>212 | 21.3<br/>0.721 | 31.8<br/>3.21 | 73.4<br/>27.5 |
| PPROM | 45<br/>9 | 2.50<br/>0.0306 | 3.73<br/>0.136 | 8.60<br/>1.17 |
| Premature Baby Death | 10<br/>0 | 0.556<br/>0.00 | 0.829<br/>0.00 | 1.91<br/>0.00 |
